Loading...
Autochthonous T cells to the rescue: IL-10 directly activates tumor-resident CD8(+) T cells
Successful cancer immunotherapy is thought to require de novo priming of tumor specific CD8(+) T cells in lymphatic organs. Contrasting these beliefs, cancer therapy based on interleukin-10 (IL-10) results in tumor rejection without a requirement for T-cell trafficking from lymphatic organs. Rather,...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3525629/ https://ncbi.nlm.nih.gov/pubmed/23264920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.21683 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|